Close the respiratory gap before it impacts your margins.


The Cause
Lung function testing remains difficult to access where care begins.
For decades, lung function testing has remained confined to specialty workflows — difficult to access, difficult to scale, and disconnected from everyday care. The result is delayed diagnosis, delayed treatment, and preventable disease escalation.

80%
undiagnosed
of people living with COPD have never been diagnosed. They go undetected, deteriorating at home until the first encounter becomes an ER visit.
86–87%
unconfirmed
of diagnosed COPD patients have never had a diagnostic test.
Cleveland Clinic found 87%.
Wake Forest found 86%.

The Effect
Undiagnosed.
Unconfirmed.
Unmanaged.
When respiratory disease goes undiagnosed or unconfirmed, the downstream impact extends across the enterprise — increasing ER utilization, weakening coding accuracy, and putting quality performance at risk.
2.5×
more ER visits
Undiagnosed respiratory disease drives avoidable ER visits, admissions, and escalation of care. Earlier diagnosis creates opportunities for earlier intervention.
Coding Integrity Risk
Respiratory diagnoses without objective confirmation become increasingly difficult to defend — creating documentation gaps, reimbursement risk, and audit vulnerability.
Quality Metric Pressure
Health systems without scalable respiratory diagnostics struggle to improve chronic disease outcomes, utilization metrics, and value-based performance.
The Solution
Deploy. Diagnose. Manage.
We built the platform for scalable respiratory diagnosis and management — designed for deployment across existing clinical teams, no respiratory specialist required.
01
Deploy
Deploy respiratory diagnostics directly into primary care, bedside workflows, and home-based care — without building new specialty infrastructure. Rapid implementation and EMR integration enable health systems to scale access quickly across care settings.


02
Diagnose
Standardized respiratory testing combined with real-time guidance and clinical decision support helps care teams identify disease earlier and make more confident treatment decisions at the point of care.
03
Manage
Extend respiratory care beyond the clinic with connected monitoring and continuous patient visibility. Care teams receive actionable insights between visits — helping identify deterioration earlier and reduce avoidable escalations.
the problem
Respiratory disease is not rare,
but diagnosing it before the ER is.
As a leading driver of inpatient admissions, early diagnosis and proactive management of lung health are vital to better patient outcomes. Expanding diagnostic access reduces costly care escalations, prevents patient leakage,
and increases patient satisfaction.
We enable diagnosis and action wherever care begins, not just after a crisis.

THE RESULT
What this means for your system.
Manage at population scale
Identify which patients require specialty intervention and manage the rest within existing care pathways — improving outcomes while reducing avoidable escalations and total cost of care.

Increase patient satisfaction
Enable same-visit respiratory testing and faster clinical direction — reducing delays, improving patient experience, and keeping care within your network.

Lower the cost of your most expensive chronic population
Earlier diagnosis and proactive monitoring help reduce exacerbations, avoidable hospitalizations, and downstream cost of care.

Protect coding accuracy and quality performance
Objective diagnostic evidence supports more accurate coding, stronger documentation integrity, risk adjustment accuracy, and performance across Star Ratings programs.

Deploy without disruption
Works with existing devices and EMR environments — enabling deployment across existing clinical teams without adding new specialty workflows.

DEPLOYMENT FLEXIBILITY
Flexible, scalable, and instantly deployable to fit your unique needs.

Simple enough for your clinic, powerful enough to change patient outcomes.
